Viatris Cardura XL 4mg Tablets Recall: Failed Impurities Risk

Take action

Contact the company & request your remedy

Recalling firmViatris Inc1000 Mylan Blvd · Canonsburg, PA 15317-5853

No email on file — write to the address above instead.

✎ GovInfoNow plain-language explainer

What happened, in plain English

Viatris is recalling Cardura XL 4mg extended-release tablets due to possible impurities that could affect safety. This recall affects specific batches made in Singapore with lot numbers 8147040 (expiring June 2024) and 8163764 (expiring March 2025).

Why it’s dangerous

The tablets may contain impurities that could affect safety, but the exact risk is not clearly described in the recall notice. The hazard is related to failed impurities or degradation specifications.

Who’s affected

People with prescriptions for Cardura XL 4mg tablets made in Singapore with the specified lot numbers are affected. Those who have these specific batches are at risk.

How to tell if you have this one

Check your Cardura XL 4mg tablets for the lot number 8147040 (expires June 2024) or 8163764 (expires March 2025). These were made in Singapore and distributed by Pfizer.

Brand
Viatris
Category
Drug

Based on the official FDA remedy

What to do — step by step

Check Your Lot Number
Look for the lot number on the bottle label: 8147040 (expires June 2024) or 8163764 (expires March 2025).

✎ GovInfoNow

Questions people ask

Do I need to stop using these tablets?

The recall does not specify a stop-use instruction, so you should check the lot number and contact your doctor if you have the affected batches.

What is the risk of these tablets?

The recall states 'Failed Impurities/Degradation Specifications' but does not describe specific health risks or injury mechanisms.

How do I know if my tablets are affected?

Check the lot number on the bottle: 8147040 (expires June 2024) or 8163764 (expires March 2025). These were made in Singapore and distributed by Pfizer.

Take action

Contact Viatris

We’ve drafted a message you can send Viatris to request your refund or repair — edit it as you like.

✉️ Open in email

Subject: Recall D-0602-2024 — Viatris Viatris

Hello,

I own a Viatris that is covered by recall D-0602-2024 from Viatris.

I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this?

Thank you.

Similar recalls

From people who’ve dealt with this

Experiences, tips, and questions from readers. Every comment is reviewed before it appears.

No comments yet — be the first to share your experience.

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-0602-2024 (April 30, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0602-2024 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.

Viatris Inc recalls Cardura XL (doxazosin) extended release tablets 4mg, 30-count bottles, Rx Only, Made in Singapore, Distributed by

Recall notice